LOXO-292 Chemical Properties

Density 

1.49±0.1 g/cm3(Predicted)

storage temp. 

Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).

solubility 

Soluble in DMSO

pka

8.23±0.40(Predicted)

form 

solid

LOXO-292 Usage And Synthesis

Description

RET-IN-1 is an oral and selective investigational drug in clinical development for the treatment of patients with cancers that harbor abnormalities in the rearranged during transfection (RET) kinase.

LOXO-292(2222755-14-6)Related Product Information

• 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid
• 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine
• 2-Amino-6-bromopyridine
• Brigatinib
• LOXO-292
• Crizotinib
• 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
• Lorlatinib (PF-06463922)
• Olaparib